MCL
Clinical trials for MCL explained in plain language.
Never miss a new study
Get alerted when new MCL trials appear
Sign up with your email to follow new studies for MCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibody therapy shows promise for Tough-to-Treat lymphomas
Disease control OngoingThis study tests a new drug called epcoritamab (GEN3013) in people with B-cell lymphoma that has come back or stopped responding to treatment. The drug is an antibody that helps the immune system attack cancer cells. The trial aims to find the best dose, check for side effects, a…
Matched conditions: MCL
Phase: PHASE1, PHASE2 • Sponsor: Genmab • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
New drug duo targets tough lymphoma
Disease control OngoingThis early study tests if combining two drugs, glofitamab and lenalidomide, can help people with mantle cell lymphoma that returned or didn't respond to prior treatments, including a BTK inhibitor. About 39 adults with this type of blood cancer will take part. The main goal is to…
Matched conditions: MCL
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 19, 2026 11:48 UTC